Skip to main content
OpenTrials
Completed

NCT Number: NCT02301403

A Comparative Effectiveness RCT of Optimized Cessation Treatments

This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Cessation Treatment (AOCT). The components for the optimized treatment have strong theoretical and empirical support from the investigators previous screening studies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health

Madison, Wisconsin, 53711, United States

About this study

The ultimate goal of this research is to develop a chronic care treatment package for smokers that will address the challenges and opportunities of each phase of the cessation process - motivation, preparation, cessation, maintenance, and relapse recovery. That is, to develop treatments for smokers not yet ready to quit, those who are preparing to quit, those actively engaged in the quitting process and those who have tried to quit but relapsed. To achieve this goal, this research comprises three distinct research studies, each of which represent a phase in a comprehensive chronic care treatment model for clinical intervention with smokers in the primary care setting: the Motivation Study, the Cessation Study, and the Long-term Quitting Study. The goal of each study is to test and identify effective intervention components for distinct phases of the smoking cessation process. These components will then be combined for future research on the effectiveness of this chronic care treatment package

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age >=18 years
  • smoking >4 cigarettes/day for the previous 6 months
  • able to read, write, and speak English
  • have reliable phone access and agree to respond to Interactive Voice Response (IVR) phone prompts
  • and if currently using NRT, agreeing to use only study medication for the duration of the study
  • we will not exclude participants based on their prior use of cessation medication or if they use multiple tobacco products in order to enhance real-world generalization (these will be statistically controlled in analyses)
  • not currently attempting to quit smoking
  • not intending to quit smoking (defined as no plans to quit in the next month)
  • and planning to remain in the intervention catchment area for at least 12 months.

Exclusion criteria

  • currently taking bupropion or varenicline
  • medical contraindications to using NRT including hospitalized (for at least one night) for a stroke, heart attack, congestive heart failure or diabetes in the last 30 days
  • diagnosis of or treatment for schizophrenia, a psychotic disorder or bipolar disorder in the last 10 years
  • and, if the participant is a woman of childbearing potential, being pregnant or intending to becoming pregnant or unwillingness to use an approved method of birth control during treatment.

Treatment and study plan

Nicotine patch

Drug

8 weeks of nicotine patch

in-person counseling and quitline counseling

Behavioral

a single brief, in-person counseling session plus a faxed referral to the Wisconsin Tobacco Quit Line (WTQL), for counseling, including the QUITNOW app and the Website

Preparation Nicotine Mini-Lozenges

Drug

Nicotine lozenge prior to attempting to quit smoking

Combination NRT (nicotine patch + nicotine mini-lozenges)

Drug

26 weeks of combination NRT as part of a quit smoking attempt

Intensive In-Person Cessation Counseling

Behavioral

three 20-min In-person Cessation Counseling sessions

Extended Maintenance Counseling Calls

Behavioral

8 Maintenance-phase smoking cessation counseling sessions

Automated Adherence Calls

Behavioral

11 brief, automated calls reminding them to use their medications properly

Primary outcomes

  1. Number of Participants With Abstinence From Smoking

    Time frame: 6 months post treatment

    The outcome measure consists of the number of participants reporting abstinence from smoking at 6 months that is biochemically confirmed (exhaled carbon monoxide < 6 parts per million).

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • Penn State University
  • University of Illinois at Chicago

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2018
First posted
Nov 25, 2014
Registry last updated
May 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.